Cumulus Neuroscience
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Concourse Building 3 Queens Rd, Belfast,...Phone Number
+44 2892646600Website
www.cumulusneuro.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cumulus Neuroscience
Cumulus Neuroscience develops an advanced at-home medical grade platform designed to address healthcare challenges in neurodegeneration and psychiatry. Their innovative tools focus on improving the monitoring and assessment of brain health by utilizing neurophysiological monitoring (EEG) and various cognitive assessments. Targeting pharmaceutical companies and clinical trial partners, Cumulus provides critical insights for more effective drug discovery and patient therapy delivery. The platform incorporates machine learning analytics, allowing for the rapid generation of meaningful data to enhance clinical outcomes.Explore more
Cumulus Neuroscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cumulus Neuroscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cumulus Neuroscience has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cumulus Neuroscience has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Cumulus Neuroscience launches new products
Earning: See what the market has to say on Cumulus Neuroscience recently announced quarterly report
Check out if Cumulus Neuroscience is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cumulus Neuroscience
Cumulus Neuroscience, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Cumulus Neuroscience had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Cumulus Neuroscience
Find 3 more new buyers
Compare Similar Companies to Cumulus Neuroscience
Compare insights from companies similar to Cumulus Neuroscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cumulus Neuroscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cumulus Neuroscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cumulus Neuroscience.
Cumulus Neuroscience financials insights
Gather financial insights about Cumulus Neuroscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Other Financing Round
$8.3M
2024
Other Financing Round
$14M
2025
Other Financing Round
$4.4M
Cumulus Neuroscience Tech Stack
A closer look at the technologies used by Cumulus Neuroscience
Most Recent Scoops
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Funding
Funding
Award
Award
Top Business Services Companies
Frequently Asked Questions Regarding Cumulus Neuroscience
Sign Up For FreeTo access detailed company insights
Cumulus Neuroscience develops an advanced at-home medical grade platform designed to address healthcare challenges in neurodegeneration and psychiatry. Their innovative tools focus on improving the monitoring and assessment of brain health by utilizing neurophysiological monitoring (EEG) and various cognitive assessments. Targeting pharmaceutical c... Read More
